+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cinitapride Market by Indication, Distribution Channel, Formulation, End User, Dosage Strength - Global Forecast to 2030- Product Image
Cinitapride Market by Indication, Distribution Channel, Formulation, End User, Dosage Strength - Global Forecast to 2030- Product Image
Sale

Cinitapride Market by Indication, Distribution Channel, Formulation, End User, Dosage Strength - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014674
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cinitapride market is adapting to dynamic shifts in gastrointestinal care, regulation, and global supply networks, requiring senior leaders to align strategy with both innovation and real-world healthcare delivery. Proactive market monitoring and evidence-based decisions are integral as industry players respond to evolving demand, technology adoption, and trade pressures.

Market Snapshot: Cinitapride Market Size and Growth

The cinitapride market grew from USD 114.78 million in 2024 to USD 120.55 million in 2025. It is forecast to expand at a CAGR of 4.79%, reaching USD 152.02 million by 2030. This sustained growth is supported by the increasing prevalence of gastrointestinal motility disorders and rising demand for patient-centric treatments across global markets.

Scope & Segmentation

  • Indication Targets: Functional dyspepsia, gastroesophageal reflux disease, and gastroparesis treatments drive major clinical adoption, with each indication requiring tailored therapeutic strategies.
  • Distribution Channels: Hospital pharmacies, online channels, and retail outlets present differentiated access points, with digital health and e-commerce supporting new patient interactions.
  • Formulation Types: Capsules, oral suspensions, and tablets offer versatile administration suitable for varying demographic needs and therapeutic settings.
  • End Users: Clinics, home care services, and hospital facilities manage dosing protocols and long-term adherence across diverse patient profiles.
  • Dosage Strengths: 0.5 mg, 1 mg, and 2 mg strengths facilitate flexible dosing, from initial therapy through escalation, ensuring precision for varied patient responses.
  • Regional Scope: Americas (notably the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major markets such as United Kingdom, Germany, France, Saudi Arabia, South Africa), and Asia-Pacific (including China, India, Japan, Australia, and other rapidly growing healthcare economies).
  • Player Coverage: Companies such as Glenmark Pharmaceuticals, Cadila Healthcare, Torrent Pharmaceuticals, Abbott India, Sun Pharmaceutical, Alkem Laboratories, Intas Pharmaceuticals, Cipla, Lupin, and Zydus Lifesciences influence innovation, distribution, and portfolio breadth.

Key Takeaways: Strategic Insights for Decision-Makers

  • Heightened regulation and post-approval quality controls are shaping compliance approaches and product lifecycle management.
  • Formulation advances, including oral suspensions and controlled-release tablets, are improving convenience for pediatric, geriatric, and difficult-to-manage patient subgroups.
  • Technology adoption, such as digital patient management and real-world evidence platforms, supports greater trial diversity and data-driven portfolio expansion.
  • Generic competition and coding of outcome-based contracts are influencing pricing dynamics and procurement strategy, especially in hospital and retail clusters.
  • Strategic alliances with domestic and regional manufacturers, including back-to-back sourcing arrangements, help stabilize the supply chain and buffer operational volatility.
  • Regional policy reforms, including reimbursement innovations and healthcare infrastructure modernization, are opening new market access pathways and shaping competitive positioning.

Tariff Impact on the Cinitapride Market

Increased tariffs in the United States from 2025 are expected to intensify input costs for APIs and formulation components. This may affect manufacturing budgets, sourcing contracts, and downstream pharmacy pricing. Companies are counterbalancing tariff exposures through diversified sourcing, domestic API partnerships, and trade advocacy, all with a focus on maintaining affordability and consistent patient access.

Methodology & Data Sources

This report integrates secondary research, including scientific literature, regulatory filings, and clinical trial data, with primary structured interviews involving clinicians, payers, and procurement leads. Validation methods such as triangulation and competitive frameworks were used to substantiate findings and segment trends.

Cinitapride Market: Why This Report Matters

  • This analysis empowers senior executives to forecast demand, benchmark emerging treatment modalities, and assess risk in procurement and market entry.
  • Strategic recommendations enable data-driven investment, operational agility, and partnerships, positioning organizations for balanced growth and competitive differentiation.

Conclusion

The cinitapride market is shaped by regulatory rigor, new technology, and shifting trade policies. Informed planning and cross-sector partnerships are essential for continued growth and improved patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cinitapride Market, by Indication
8.1. Introduction
8.2. Functional Dyspepsia
8.3. Gastroesophageal Reflux Disease
8.4. Gastroparesis
9. Cinitapride Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Cinitapride Market, by Formulation
10.1. Introduction
10.2. Capsules
10.3. Oral Suspension
10.4. Tablets
11. Cinitapride Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Cinitapride Market, by Dosage Strength
12.1. Introduction
12.2. 0.5 Milligram
12.3. 1 Milligram
12.4. 2 Milligram
13. Americas Cinitapride Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cinitapride Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cinitapride Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Glenmark Pharmaceuticals Limited
16.3.2. Cadila Healthcare Limited
16.3.3. Torrent Pharmaceuticals Limited
16.3.4. Abbott India Limited
16.3.5. Sun Pharmaceutical Industries Limited
16.3.6. Alkem Laboratories Limited
16.3.7. Intas Pharmaceuticals Limited
16.3.8. Cipla Limited
16.3.9. Lupin Limited
16.3.10. Zydus Lifesciences Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CINITAPRIDE MARKET MULTI-CURRENCY
FIGURE 2. CINITAPRIDE MARKET MULTI-LANGUAGE
FIGURE 3. CINITAPRIDE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CINITAPRIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CINITAPRIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CINITAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CINITAPRIDE MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CINITAPRIDE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CINITAPRIDE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CINITAPRIDE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CINITAPRIDE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CINITAPRIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CINITAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CINITAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CINITAPRIDE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CINITAPRIDE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CINITAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CINITAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CINITAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CINITAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CINITAPRIDE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CINITAPRIDE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CINITAPRIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CINITAPRIDE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CINITAPRIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CINITAPRIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CINITAPRIDE MARKET SIZE, BY FUNCTIONAL DYSPEPSIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CINITAPRIDE MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CINITAPRIDE MARKET SIZE, BY GASTROPARESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CINITAPRIDE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CINITAPRIDE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CINITAPRIDE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CINITAPRIDE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CINITAPRIDE MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CINITAPRIDE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CINITAPRIDE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CINITAPRIDE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CINITAPRIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CINITAPRIDE MARKET SIZE, BY 0.5 MILLIGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CINITAPRIDE MARKET SIZE, BY 1 MILLIGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CINITAPRIDE MARKET SIZE, BY 2 MILLIGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CINITAPRIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CINITAPRIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. CANADA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. CANADA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. CANADA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. CANADA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 43. MEXICO CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. MEXICO CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA CINITAPRIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED KINGDOM CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 69. GERMANY CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. GERMANY CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. GERMANY CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 72. GERMANY CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. GERMANY CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 74. FRANCE CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. FRANCE CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. FRANCE CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 77. FRANCE CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. FRANCE CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 84. ITALY CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. ITALY CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. ITALY CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 87. ITALY CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. ITALY CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 89. SPAIN CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. SPAIN CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. SPAIN CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 92. SPAIN CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. SPAIN CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. SAUDI ARABIA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. SOUTH AFRICA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 109. DENMARK CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. DENMARK CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. DENMARK CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 112. DENMARK CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. DENMARK CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. NETHERLANDS CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 119. QATAR CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. QATAR CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. QATAR CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 122. QATAR CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. QATAR CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 124. FINLAND CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. FINLAND CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. FINLAND CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. FINLAND CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. FINLAND CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 139. EGYPT CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. EGYPT CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. EGYPT CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. EGYPT CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 144. TURKEY CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. TURKEY CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. TURKEY CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 147. TURKEY CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. TURKEY CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 154. NORWAY CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. NORWAY CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. NORWAY CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. NORWAY CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. NORWAY CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 159. POLAND CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. POLAND CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. POLAND CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. POLAND CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. POLAND CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. SWITZERLAND CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC CINITAPRIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 175. CHINA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. CHINA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. CHINA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. CHINA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. CHINA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 180. INDIA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. INDIA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. INDIA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 183. INDIA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. INDIA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 185. JAPAN CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. JAPAN CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. JAPAN CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 188. JAPAN CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. JAPAN CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 205. THAILAND CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. THAILAND CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. THAILAND CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 208. THAILAND CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. THAILAND CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN CINITAPRIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN CINITAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN CINITAPRIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN CINITAPRIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN CINITAPRIDE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 235. CINITAPRIDE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 236. CINITAPRIDE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cinitapride market report include:
  • Glenmark Pharmaceuticals Limited
  • Cadila Healthcare Limited
  • Torrent Pharmaceuticals Limited
  • Abbott India Limited
  • Sun Pharmaceutical Industries Limited
  • Alkem Laboratories Limited
  • Intas Pharmaceuticals Limited
  • Cipla Limited
  • Lupin Limited
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 120.55 Million
Forecasted Market Value ( USD ) by 2030 $ 152.02 Million
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cinitapride (CAS 66564-14-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Cinitapride (CAS 66564-14-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Cimetropium bromide Market by Indication, Distribution Channel, Route of Administration, Formulation, End User, Dosage Strength - Global Forecast to 2030 - Product Image

Cimetropium bromide Market by Indication, Distribution Channel, Route of Administration, Formulation, End User, Dosage Strength - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Fenoverine Market by Form, Indication, Distribution Channel, End User, Dosage Strength, Route of Administration - Global Forecast to 2030 - Product Image

Fenoverine Market by Form, Indication, Distribution Channel, End User, Dosage Strength, Route of Administration - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Gastroretentive Drug Delivery Systems Market Size, Share & Trends Analysis Report by Type (Floating, Expandable), Dosage (Tablets, Capsule, Gel, Liquid), Distribution Channel, Region, and Segment Forecasts, 2025-2030 - Product Image

Gastroretentive Drug Delivery Systems Market Size, Share & Trends Analysis Report by Type (Floating, Expandable), Dosage (Tablets, Capsule, Gel, Liquid), Distribution Channel, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Remicade Market Size, Share & Trends Analysis Report by Type (Branded, Biosimilar), Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Remicade Market Size, Share & Trends Analysis Report by Type (Branded, Biosimilar), Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From

About the Cinitapride Market

Cinitapride is a gastrointestinal drug used to treat gastrointestinal motility disorders. It is a prokinetic agent, meaning it increases the movement of the gastrointestinal tract. It is used to treat symptoms such as abdominal pain, bloating, and constipation. Cinitapride is available in both oral and injectable forms. It is typically used in combination with other medications to treat gastrointestinal disorders. The cinitapride market is a growing segment of the gastrointestinal drugs market. It is used to treat a variety of gastrointestinal disorders, including irritable bowel syndrome, gastroesophageal reflux disease, and functional dyspepsia. It is also used to treat symptoms associated with delayed gastric emptying. Some companies in the cinitapride market include AstraZeneca, Merck, Pfizer, and Sanofi. These companies produce both oral and injectable forms of the drug. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.